Cormorant Asset Management, LP Bio N Tech Se Transaction History

Cormorant Asset Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$113.32 - $241.49 $11.3 Million - $24.1 Million	-100,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$85.73 - $119.5 $15 Million - $20.9 Million	-175,000 Reduced 63.64%	100,000 $10.9 Million
Q4 2020 Feb 16, 2021	SELL	$72.71 - $129.54 $3.64 Million - $6.48 Million	-50,000 Reduced 15.38%	275,000 $22.4 Million
Q3 2020 Nov 16, 2020	BUY	$57.81 - $104.17 $8.67 Million - $15.6 Million	150,000 Added 85.71%	325,000 $22.4 Million
Q2 2020 Aug 14, 2020	BUY	$38.58 - $66.74 $6.75 Million - $11.7 Million	175,000 New	175,000 $11.7 Million

364

39.6M

3.01M

2.01M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24.1B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.